Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty - ARMYDA-8 RELOAD-ACS

Description:

The goal of the trial was to evaluate a clopidogrel reload among patients with non–ST-segment elevation myocardial infarction (NSTEMI) on chronic clopidogrel therapy undergoing percutaneous coronary intervention (PCI) compared with placebo.